| Discontinued operations |
19 Discontinued operations On April 15, 2026, Aegon announced it has reached an agreement on the sale of Aegon UK plc (’’Aegon UK”), containing Aegon’s UK insurance and pensions operations, to Standard Life Plc (’’Standard Life”), a publicly traded company on the London stock exchange. In connection with such sale, Aegon will receive GBP 750 million in gross cash proceeds and a 15.3% shareholding in Standard Life ordinary shares, with associated governance rights. Any remittances taken out of Aegon UK between the signing and closing of the transaction will be deducted from the GBP 750 million cash amount. The transaction is expected to close around the end of 2026, subject to customary conditions, including regulatory approvals. Aegon’s asset management activities in the UK will remain part of Aegon’s global asset manager and will be an important asset management partner for the new combined business. This note presents the disclosures related to Aegon UK, which is reported as United Kingdom segment in note 3 Segment information , qualified as held for sale and discontinued operations as from the date of the agreement of the sale. In addition, the impact of this transaction on Aegon’s risk profile and capital position can be referred to note 15 Financial risks and note 16 Capital management and solvency . Risk free yield curves in GBP and illiquidity premiums for Aegon UK’s significant portfolios can be referred to note 12.3 Critical judgements and estimates . 19.1 Condensed income statement
|
|
|
|
|
|
|
|
|
|
|
|
Amounts in EUR millions (except per share data) |
|
1H 2026 |
|
|
1H 2025 |
|
|
|
|
Discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
Insurance revenue |
|
|
212 |
|
|
|
211 |
|
|
|
|
Insurance service expenses |
|
|
(78 |
) |
|
|
(86 |
) |
|
|
|
Insurance service result |
|
|
134 |
|
|
|
125 |
|
|
|
|
Interest revenue on financial instruments calculated using the effective interest method |
|
|
13 |
|
|
|
14 |
|
|
|
|
Interest income from instruments measured at FVPL |
|
|
117 |
|
|
|
173 |
|
|
|
|
Other investment income |
|
|
732 |
|
|
|
820 |
|
|
|
|
Results from financial transactions |
|
|
4,224 |
|
|
|
1,011 |
|
|
|
|
Insurance finance income / (expenses) |
|
|
(5,136 |
) |
|
|
(2,024 |
) |
|
|
|
Net reinsurance finance income / (expenses) on reinsurance held |
|
|
(2 |
) |
|
|
(1 |
) |
|
|
|
Insurance net investment result |
|
|
|
|
|
|
|
|
|
|
|
Interest revenue on financial instruments calculated using the effective interest method |
|
|
17 |
|
|
|
19 |
|
|
|
|
Interest income from instruments measured at FVPL |
|
|
31 |
|
|
|
58 |
|
|
|
|
Other investment income |
|
|
560 |
|
|
|
600 |
|
|
|
|
Results from financial transactions |
|
|
5,029 |
|
|
|
366 |
|
|
|
|
Investment contract income / (expenses) |
|
|
(5,633 |
) |
|
|
(1,028 |
) |
|
|
|
Interest expenses |
|
|
- |
|
|
|
1 |
|
|
|
|
Other net investment result |
|
|
|
|
|
|
|
|
|
|
|
Total net investment result |
|
|
(48 |
) |
|
|
8 |
|
|
|
|
Fees and commission income |
|
|
167 |
|
|
|
149 |
|
|
|
|
Other operating expenses |
|
|
(187 |
) |
|
|
(179 |
) |
|
|
|
Other income / (charges) |
|
|
4 |
|
|
|
5 |
|
|
|
|
Other result |
|
|
(17 |
) |
|
|
(26 |
) |
|
|
|
Result before tax from discontinued operations |
|
|
69 |
|
|
|
107 |
|
|
|
|
Income tax (expense) / benefit |
|
|
(17 |
) |
|
|
(22 |
) |
|
|
|
Result after tax from discontinued operations |
|
|
52 |
|
|
|
86 |
|
|
|
|
Impairment loss on remeasurement of the disposal group |
|
|
- |
|
|
|
- |
|
|
|
|
Net result from discontinued operations 1 |
|
|
52 |
|
|
|
86 |
|
|
|
|
Earnings per share from discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share |
|
|
0.03 |
|
|
|
0.05 |
|
|
|
|
Basic earnings per common share B |
|
|
0.00 |
|
|
|
0.00 |
|
|
|
|
Diluted earnings per common share |
|
|
0.03 |
|
|
|
0.05 |
|
|
|
|
Diluted earnings per common share B |
|
|
0.00 |
|
|
|
0.00 |
|
1 |
Net result from discontinued operations equals to the sum of Net result of Aegon UK (third party result) and the Inter-segment result ( intercompany result), both under 3.1 Segment results . | 19.2 Condensed statement of comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
1H 2026 |
|
|
1H 2025 |
|
|
|
|
Net result from discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
Items that will not be reclassified to profit or loss: |
|
|
|
|
|
|
|
|
|
|
|
Remeasurements of defined benefit plans |
|
|
(27 |
) |
|
|
6 |
|
|
|
|
Items that may be reclassified subsequently to profit or loss: |
|
|
|
|
|
|
|
|
|
|
|
Movement in foreign currency translation and net foreign investment hedging reserves |
|
|
16 |
|
|
|
(52 |
) |
|
|
|
Total other comprehensive income / (loss) from discontinued operations |
|
|
|
|
|
|
(45 |
) |
|
|
|
Total comprehensive income / (loss) from discontinued operations |
|
|
41 |
|
|
|
40 |
| 19.3 Condensed held for sale assets and liabilities
|
|
|
|
|
|
|
| |
|
June 30, 2026 |
|
|
|
Assets |
|
|
|
|
|
|
Cash and cash equivalents |
|
|
250 |
|
|
|
Investments |
|
|
136,640 |
|
|
|
Derivatives |
|
|
53 |
|
|
|
Reinsurance contract assets |
|
|
1 |
|
|
|
Deferred tax assets |
|
|
74 |
|
|
|
Deferred expenses |
|
|
13 |
|
|
|
Other assets and receivables |
|
|
1,084 |
|
|
|
Intangible assets |
|
|
131 |
|
|
|
Total assets held for sale |
|
|
138,246 |
|
|
|
Liabilities |
|
|
|
|
|
|
Reinsurance contract liabilities |
|
|
5 |
|
|
|
Insurance contract liabilities |
|
|
46,857 |
|
|
|
Investment contract liabilities with discretionary participation features |
|
|
21,777 |
|
|
|
Investment contracts without discretionary participation features |
|
|
67,438 |
|
|
|
Derivatives |
|
|
196 |
|
|
|
Other liabilities |
|
|
797 |
|
|
|
Total liabilities held for sale |
|
|
137,070 |
| 19.4 Condensed cash flow statement
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
1H 2026 |
|
|
1H 2025 |
|
|
|
|
Net cash inflow (outflow) from operating activities |
|
|
114 |
|
|
|
81 |
|
|
|
|
Net cash inflow (outflow) from investing activities |
|
|
(2 |
) |
|
|
(6 |
) |
|
|
|
Net cash inflow (outflow) from financing activities |
|
|
(76 |
) |
|
|
(69 |
) |
|
|
|
Net cash inflow (outflow) from discontinued operations |
|
|
35 |
|
|
|
5 |
| 19.5 Impairment assessment Upon classification as held for sale, as per June 30, 2026, the carrying amount of Aegon UK has been compared to the fair value less cost to sell, which is estimated by reference to the fair value of the consideration to which Aegon Ltd. is entitled under the terms and conditions of the sales agreement. The fair value less cost to sell is higher than the carrying value and thus an impairment loss is not applicable.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds |
|
Number |
|
|
Share price |
|
|
GBP |
|
|
EUR |
|
Cash (in million) |
|
|
|
|
|
|
|
|
|
|
750 |
|
|
|
871 |
|
|
|
|
|
|
Shares |
|
|
181,080,690 |
|
|
|
8.33 |
|
|
|
1,508 |
|
|
|
1,752 |
|
|
|
|
|
|
Total consideration |
|
|
|
|
|
|
|
|
|
|
2,258 |
|
|
|
2,622 |
|
|
|
|
|
|
Cost to sell |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(44 |
) |
|
|
|
|
|
Dividend |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(59 |
) |
|
|
|
|
|
Fair value less cost to sell |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying amount of Aegon UK |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,183 |
| The impairment assessment takes into account contingent payables and receivables between Aegon Ltd. and Aegon UK that are recognized prior to the closing date. These are included in the carrying amount of Aegon UK. The fair value less cost to sell is level I of the fair value hierarchy, as it includes the share price of Standard Life, which is quoted on the London Stock Exchange and the cash consideration. 19.6 Fair value The following table sets out the fair values of financial instruments by the level of the fair value hierarchy into which each fair value measurement is categorized. It does not include fair value information for cash and cash equivalents, receivables, and payables, whose carrying amounts are a reasonable approximation of fair value, or for lease liabilities.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Fair value hierarchy |
|
|
|
|
|
|
June 30, 2026 |
|
|
Level I |
|
|
|
Level II |
|
|
|
Level III |
|
|
|
Total |
|
|
|
|
|
|
Shares |
|
|
- |
|
|
|
13 |
|
|
|
- |
|
|
|
13 |
|
|
|
|
|
|
Debt securities |
|
|
255 |
|
|
|
308 |
|
|
|
- |
|
|
|
563 |
|
|
|
|
|
|
Money market and other short-term investments |
|
|
- |
|
|
|
126 |
|
|
|
- |
|
|
|
126 |
|
|
|
|
|
|
Other investments at fair value |
|
|
- |
|
|
|
659 |
|
|
|
- |
|
|
|
659 |
|
|
|
|
|
|
Derivatives |
|
|
10 |
|
|
|
35 |
|
|
|
8 |
|
|
|
53 |
|
|
|
|
|
|
Investments - Policyholder risk |
|
|
16,743 |
|
|
|
117,758 |
|
|
|
332 |
|
|
|
134,832 |
|
|
|
|
|
|
Total financial assets measured at FVPL |
|
|
17,008 |
|
|
|
118,899 |
|
|
|
340 |
|
|
|
136,248 |
|
|
|
|
|
|
Investment contracts without DPF - Policyholder risk |
|
|
- |
|
|
|
67,408 |
|
|
|
- |
|
|
|
67,408 |
|
|
|
|
|
|
Derivatives |
|
|
15 |
|
|
|
180 |
|
|
|
- |
|
|
|
196 |
|
|
|
|
|
|
Total financial liabilities measured at fair value |
|
|
15 |
|
|
|
67,588 |
|
|
|
- |
|
|
|
67,603 |
| Movements in Level III financial instruments measured at fair value The following table summarizes the change of all assets and liabilities measured at estimated fair value on a recurring basis using significant unobservable inputs (Level III), including realized and unrealized gains (losses) of all assets and liabilities and unrealized gains (losses) of all assets and liabilities still held at the end of the respective period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Transfers to disposal groups |
|
|
Total gains / (losses) in income |
|
|
Purch- ases |
|
|
Sales |
|
|
Settle- ments |
|
|
Net ex- change difference |
|
|
On June 30, 2026 |
|
|
Total URGL |
|
|
|
|
|
|
|
|
|
|
Derivatives |
|
|
10 |
|
|
|
(1) |
|
|
|
- |
|
|
|
(1) |
|
|
|
- |
|
|
|
- |
|
|
|
8 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
Investments - Policyholder risk |
|
|
307 |
|
|
|
3 |
|
|
|
38 |
|
|
|
(17) |
|
|
|
- |
|
|
|
2 |
|
|
|
332 |
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
Total financial assets (FVPL) |
|
|
316 |
|
|
|
2 |
|
|
|
38 |
|
|
|
(18) |
|
|
|
- |
|
|
|
2 |
|
|
|
340 |
|
|
|
2 |
|
1 |
Includes impairments and movements related to fair value hedges. Gains and losses are recorded in the line item Results from financial transactions of the income statement. |
2 |
Total unrealized gains / (losses) for the period recorded in the P&L during which the financial instrument was in Level III. | There were no transfers to or from level I and level II in the first half year of 2026. 19.7 Insurance contracts and investment contracts with discretionary participation features
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1H 2026 |
|
Insurance contracts (Non-PAA) |
|
|
Investment contracts with DPF |
|
|
|
|
|
|
|
|
|
|
Movement schedules by type of liability |
|
LFRC |
|
|
LC |
|
|
LFIC |
|
|
Total |
|
|
LFRC |
|
|
LC |
|
|
LFIC |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transfers to disposal groups |
|
|
42,936 |
|
|
|
11 |
|
|
|
29 |
|
|
|
42,977 |
|
|
|
20,194 |
|
|
|
1 |
|
|
|
- |
|
|
|
20,196 |
|
|
|
|
|
|
|
|
|
|
Insurance revenue |
|
|
(94 |
) |
|
|
- |
|
|
|
- |
|
|
|
(94 |
) |
|
|
(21 |
) |
|
|
- |
|
|
|
- |
|
|
|
(21 |
) |
|
|
|
|
|
|
|
|
|
Incurred claims and expenses |
|
|
- |
|
|
|
- |
|
|
|
35 |
|
|
|
35 |
|
|
|
- |
|
|
|
- |
|
|
|
6 |
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
Onerous contract losses (and reversals) |
|
|
- |
|
|
|
(4 |
) |
|
|
- |
|
|
|
(4 |
) |
|
|
- |
|
|
|
(1 |
) |
|
|
- |
|
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
Insurance service expenses |
|
|
- |
|
|
|
(4 |
) |
|
|
35 |
|
|
|
31 |
|
|
|
- |
|
|
|
(1 |
) |
|
|
6 |
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
Investment components |
|
|
(1,362 |
) |
|
|
- |
|
|
|
1,362 |
|
|
|
- |
|
|
|
(746 |
) |
|
|
- |
|
|
|
746 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Insurance service result |
|
|
(1,456 |
) |
|
|
(4 |
) |
|
|
1,397 |
|
|
|
(62 |
) |
|
|
(767 |
) |
|
|
(1 |
) |
|
|
752 |
|
|
|
(16 |
) |
|
|
|
|
|
|
|
|
|
Insurance finance (income) / expenses |
|
|
4,390 |
|
|
|
- |
|
|
|
- |
|
|
|
4,390 |
|
|
|
2,110 |
|
|
|
- |
|
|
|
- |
|
|
|
2,110 |
|
|
|
|
|
|
|
|
|
|
Cash flows |
|
|
621 |
|
|
|
- |
|
|
|
(1,398 |
) |
|
|
(777 |
) |
|
|
86 |
|
|
|
- |
|
|
|
(752 |
) |
|
|
(666 |
) |
|
|
|
|
|
|
|
|
|
Net exchange differences |
|
|
329 |
|
|
|
- |
|
|
|
- |
|
|
|
330 |
|
|
|
153 |
|
|
|
- |
|
|
|
- |
|
|
|
153 |
|
|
|
|
|
|
|
|
|
|
Net closing balance |
|
|
46,821 |
|
|
|
7 |
|
|
|
29 |
|
|
|
46,857 |
|
|
|
21,776 |
|
|
|
- |
|
|
|
- |
|
|
|
21,777 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1H 2026 |
|
Insurance contracts (Non-PAA) |
|
|
Investment contracts with DPF |
|
|
|
|
|
|
|
|
|
|
Movement schedules by measurement component |
|
BEL |
|
|
RA |
|
|
CSM |
|
|
Total |
|
|
BEL |
|
|
RA |
|
|
CSM |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Transfers to disposal groups |
|
|
41,515 |
|
|
|
218 |
|
|
|
1,244 |
|
|
|
42,977 |
|
|
|
19,891 |
|
|
|
90 |
|
|
|
214 |
|
|
|
20,196 |
|
|
|
|
|
|
|
|
|
|
Changes in estimates that adjust CSM |
|
|
(171 |
) |
|
|
23 |
|
|
|
149 |
|
|
|
- |
|
|
|
(92 |
) |
|
|
11 |
|
|
|
81 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Changes in estimates that adjust onerous contracts |
|
|
(4 |
) |
|
|
- |
|
|
|
- |
|
|
|
(4 |
) |
|
|
(1 |
) |
|
|
- |
|
|
|
- |
|
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
Changes that relate to future service |
|
|
(176 |
) |
|
|
23 |
|
|
|
149 |
|
|
|
(4 |
) |
|
|
(93 |
) |
|
|
11 |
|
|
|
81 |
|
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
Earnings released from CSM |
|
|
- |
|
|
|
- |
|
|
|
(43 |
) |
|
|
(43 |
) |
|
|
- |
|
|
|
- |
|
|
|
(12 |
) |
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
Release of risk adjustment |
|
|
- |
|
|
|
(6 |
) |
|
|
- |
|
|
|
(6 |
) |
|
|
- |
|
|
|
(3 |
) |
|
|
- |
|
|
|
(3 |
) |
|
|
|
|
|
|
|
|
|
Revenue from policyholder tax expenses incurred |
|
|
(10 |
) |
|
|
- |
|
|
|
- |
|
|
|
(10 |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Changes that relate to current service |
|
|
(10 |
) |
|
|
(6 |
) |
|
|
(43 |
) |
|
|
(59 |
) |
|
|
- |
|
|
|
(3 |
) |
|
|
(12 |
) |
|
|
(15 |
) |
|
|
|
|
|
|
|
|
|
Insurance service result |
|
|
(185 |
) |
|
|
17 |
|
|
|
105 |
|
|
|
(62 |
) |
|
|
(93 |
) |
|
|
8 |
|
|
|
70 |
|
|
|
(16 |
) |
|
|
|
|
|
|
|
|
|
General model |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest accreted to insurance contracts |
|
|
4 |
|
|
|
- |
|
|
|
1 |
|
|
|
6 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Variable fee approach |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of the underlying assets |
|
|
4,385 |
|
|
|
- |
|
|
|
- |
|
|
|
4,385 |
|
|
|
2,110 |
|
|
|
- |
|
|
|
- |
|
|
|
2,110 |
|
|
|
|
|
|
|
|
|
|
Change in fulfilment value - risk mitigation option |
|
|
(1 |
) |
|
|
- |
|
|
|
- |
|
|
|
(1 |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Insurance finance (income) / expenses |
|
|
4,389 |
|
|
|
- |
|
|
|
1 |
|
|
|
4,390 |
|
|
|
2,110 |
|
|
|
- |
|
|
|
- |
|
|
|
2,110 |
|
|
|
|
|
|
|
|
|
|
Premiums received |
|
|
620 |
|
|
|
- |
|
|
|
- |
|
|
|
620 |
|
|
|
90 |
|
|
|
- |
|
|
|
- |
|
|
|
90 |
|
|
|
|
|
|
|
|
|
|
Claims, benefits and expenses paid |
|
|
(1,397 |
) |
|
|
- |
|
|
|
- |
|
|
|
(1,397 |
) |
|
|
(756 |
) |
|
|
- |
|
|
|
- |
|
|
|
(756 |
) |
|
|
|
|
|
|
|
|
|
Cash flows |
|
|
(777 |
) |
|
|
- |
|
|
|
- |
|
|
|
(777 |
) |
|
|
(666 |
) |
|
|
- |
|
|
|
- |
|
|
|
(666 |
) |
|
|
|
|
|
|
|
|
|
Net exchange differences |
|
|
318 |
|
|
|
2 |
|
|
|
10 |
|
|
|
330 |
|
|
|
150 |
|
|
|
1 |
|
|
|
2 |
|
|
|
153 |
|
|
|
|
|
|
|
|
|
|
Net closing balance |
|
|
45,260 |
|
|
|
237 |
|
|
|
1,361 |
|
|
|
46,857 |
|
|
|
21,393 |
|
|
|
98 |
|
|
|
286 |
|
|
|
21,777 |
| 19.8 Investment contracts without discretionary participation features
|
|
|
|
|
|
|
|
|
| |
|
1H 2026 |
|
|
|
|
Movement schedule |
|
Aegon risk |
|
|
Policyholder risk |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
|
Transfers to disposal groups |
|
|
31 |
|
|
|
59,035 |
|
|
|
|
Deposits |
|
|
1 |
|
|
|
2,637 |
|
|
|
|
Withdrawals |
|
|
(2 |
) |
|
|
(1,572 |
) |
|
|
|
Interest credited |
|
|
- |
|
|
|
6,882 |
|
|
|
|
Fund charges released |
|
|
- |
|
|
|
(48 |
) |
|
|
|
Net exchange differences |
|
|
- |
|
|
|
474 |
|
|
|
|
Closing balance |
|
|
31 |
|
|
|
67,408 |
|
|